Filing Flows › Profound Medical (PROF) › Q2 2025
Profound Medical (PROF) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 14, 2025
Profound Medical (PROF) reported revenue of $2.2M for the second quarter 2025 (Q2 2025), -1% from a year earlier and -16% from the quarter before. Operating margin was -624.4%, net loss $15.7M (709.9% of revenue).
Profound Medical, Q2 2025: revenue $2.2M (-1% year over year), operating margin -624.4%, net loss $15.7M, operating cash flow −$13.7M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | -16% | -1% |
| Operating profit | −$13.8M | — | — |
| Net earnings | −$15.7M | — | — |
| Operating cash flow | −$13.7M | — | — |
What changed
Revenue was $2.2M in Q2 2025, down 1% year over year and down 16% from the previous quarter. Recurring - non-capital was the largest line at 71% of revenue. Capital equipment lost $123K year over year (down 16%), 559% of the total change.
Gross margin was 73.2%, up 9.5 points from a year earlier. Operating costs exceeded revenue by $13.8M, an operating margin of -624.4%. Operating expenses grew 67% against a revenue fall of 1%. The fastest-growing cost line was SG&A (+84%). The quarter ended with a net loss of $15.7M, wider than the previous quarter's $10.7M loss.
Operating cash flow was −$13.7M. Non-cash charges added back $141K of depreciation and amortization and $1.5M of share-based compensation.
Questions
What was Profound Medical's revenue in the second quarter 2025?
Profound Medical (PROF) reported revenue of $2.2M for the second quarter 2025 (Q2 2025), -1% from a year earlier and -16% from the quarter before.
Was Profound Medical profitable in the second quarter 2025?
Operating loss was $13.8M (-624.4% of revenue) and net loss $15.7M.
Source: Profound Medical 10-Q on SEC EDGAR.